Statements (35)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:syndrome
|
| gptkbp:alsoKnownAs |
gptkb:anticholinergic_toxicity
|
| gptkbp:causedBy |
gptkb:tricyclic_antidepressants
scopolamine antipsychotics anticholinergic drugs atropine antihistamines antiparkinsonian drugs |
| gptkbp:complication |
coma
seizures cardiac arrhythmias |
| gptkbp:diagnosedBy |
clinical evaluation
|
| gptkbp:differentialDiagnosis |
gptkb:serotonin_syndrome
gptkb:sympathomimetic_toxicity neuroleptic malignant syndrome |
| gptkbp:firstDescribed |
20th century
|
| gptkbp:riskFactor |
elderly patients
polypharmacy |
| gptkbp:symptom |
delirium
mydriasis tachycardia hyperthermia hallucinations dry mouth urinary retention dry skin decreased bowel sounds flushed skin |
| gptkbp:treatment |
gptkb:physostigmine
supportive care |
| gptkbp:bfsParent |
gptkb:Datura_stramonium
gptkb:anticholinergic_toxicity |
| gptkbp:bfsLayer |
8
|
| https://www.w3.org/2000/01/rdf-schema#label |
anticholinergic syndrome
|